PTS Diagnostics Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • PTS Diagnostics's estimated annual revenue is currently $67M per year.(i)
  • PTS Diagnostics's estimated revenue per employee is $155,000

Employee Data

  • PTS Diagnostics has 432 Employees.(i)
  • PTS Diagnostics grew their employee count by 15% last year.

PTS Diagnostics's People

NameTitleEmail/Phone
1
VP Sales, USReveal Email/Phone
2
VP Global MarketingReveal Email/Phone
3
VP and General ManagerReveal Email/Phone
4
National Sale DirectorReveal Email/Phone
5
Senior Director, Quality and Regulatory AffairsReveal Email/Phone
6
Director Channel SalesReveal Email/Phone
7
Director OperationsReveal Email/Phone
8
Sr. Director Customer and Technical SupportReveal Email/Phone
9
Medical DirectorReveal Email/Phone
10
Chief Commercial OfficerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.8M5-17%N/AN/A
#2
$5.7M376%N/AN/A
#3
$10.2M666%N/AN/A
#4
$2.3M1515%N/AN/A
#5
$2M130%N/AN/A
#6
$7.6M49-2%N/AN/A
#7
$0.8M5-17%N/AN/A
#8
$7.9M516%N/AN/A
#9
$37.7M243-2%N/AN/A
#10
$1.6M100%N/AN/A
Add Company

What Is PTS Diagnostics?

PTS Diagnostics is an innovative point-of-care diagnostics solutions provider that partners with patients and healthcare professionals to provide the right information at the right time to make the right decisions. The company's name represents the three pillars upon which it has built its long-term success: People, Technology and Service. PTS Diagnostics signature products include the CardioChek® lipid analyzer and the A1CNow® family of products. The CardioChek® family of products have screened more than 120 million patients worldwide while the A1CNow® product line works to enable people to lead healthier lives through ongoing management of diabetes. Together these products help identify individuals with cardiometabolic syndrome, a cluster of conditions that increases the risks of developing cardiovascular disease or diabetes.

keywords:Biotechnology,Hardware,Hardware Peripherals,Healthcare,Medical Devices,Medical Diagnostics

N/A

Total Funding

432

Number of Employees

$67M

Revenue (est)

15%

Employee Growth %

N/A

Valuation

N/A

Accelerator

PTS Diagnostics News

2022-04-20 - Cholesterol Test Kits Consumption Market Size, Share ...

Cholesterol Test Kits Consumption Market Size, Share, Forecast 2022-2029| Key Players – Alere, Roche, PTS Diagnostics, Beckman Coulter.

2022-04-20 - POC HbA1C Testing Market Size, Scope And Forecast ...

... Roche, Bio-Rad, GREEN CROSS MEDIS, Trinity Biotech, HUMAN Diagnostics, Sinocare (PTS Diagnostics), Erba Diagnostics, EKF Diagnostics.

2022-04-17 - Blood Fat Analyzer Market Set to Witness Explosive Growth by ...

Blood Fat Analyzer Market Set to Witness Explosive Growth by 2029 | PTS Diagnostics, Alere, Acon. Photo of a2z a2zApril 13, 2022. 0 3 minutes read.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$177.5M43311%N/A
#2
$79.9M434-1%$25.1M
#3
$181.5M44020%N/A
#4
$102.2M4544%N/A
#5
$165.3M4568%N/A